Metabolon Develops Software Method to Automate the Organization of LC/MS and GC/MS Libraries
RESEARCH TRIANGLE PARK, N.C. (October 19, 2010)—Metabolon, Inc., leaders in global metabolomics, biomarker discovery and biochemical analysis, announces the online publication of “Organization of GC/MS and LC/MS Metabolomics Data into Chemical Libraries” in the Journal of Cheminformatics. The article describes the automated identification of individual compounds based on the biological variability in compound concentrations across multiple samples. A US patent, US7,561,975, has been issued to Metabolon on the methodology described in the paper.
To access the article please click here.
Metabolon is a diagnostics and services company offering the industry’s leading biochemical profiling platform. Metabolon’s patented platform provides a global analysis of complex biological samples for the discovery of markers and pathways associated with drug action and disease. This metabolomics-driven approach enables the identification of biomarkers useful for the development of a wide range of diagnostics and provides insight into complex biochemical processes such as drug action, toxicology and bioprocess optimization. For more information about Metabolon, please visit www.metabolon.com or contact Matt Zaske firstname.lastname@example.org or (919) 595-2200.